Hematopoietic stem cell transplantation for classical inherited bone marrow failure syndromes: an update

References

• Li Q, Luo C, Luo C, et al. Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes. Ann Hematol. 2017;96(8):1389–1397.
   PubMed Web of Science ®Google Scholar
• Kallen MR, Dulau-Florea A, Wang W, et al. Acquired and germline predisposition to bone marrow failure: diagnostic features and clinical implications. Semin Hematol. 2019;56(1):69–82.
   PubMed Web of Science ®Google Scholar
• Bluteau O, Sebert M, Leblanc T, et al. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. Blood. 2018;131(7):717–732.
   PubMed Web of Science ®Google Scholar
• Zhang MY, Keel SB, Walsh T, et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica. 2015;100(1):42–48.
   PubMed Web of Science ®Google Scholar
• Seidel M. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood. 2014;124(15):2337–2344.
   PubMed Web of Science ®Google Scholar
• Keel SB, Scott A, Sanchez-Bonilla M, et al. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients. Haematologica. 2016;101(11):1343–1350.
   Google Scholar
• Díaz De Heredia C, Bierings M, Dalle JH, et al. Fanconi’s anemia and other hereditary bone marrow failure syndromes. In: Carreras E, Dufour C, Mohty M, et al., editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. 7th ed. Cham (Switzerland): Springer; 2019. p. 587.
   Google Scholar
• Peffault de Latour R, Peters C, Gibson B et alRecommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes. Bone Marrow Transplant. 2015;50(9):1168–72
   Google Scholar
• Alter BP. Inherited bone marrow failure syndromes: considerations pre- and post- transplant. Blood. 2017;130(21):2257–2264.
   PubMed Web of Science ®Google Scholar
• Dietz AC, Savage SA, Vlachos A, et al. Late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes: consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. Biol Blood Marrow Transplant. 2017;23(9):1422–1428.
   PubMed Web of Science ®Google Scholar
• Alter BP, Giri N, Savage SA, et al. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica. 2018;103(1):30–39.
   PubMed Web of Science ®Google Scholar
• Dufour C. How I manage patients with Fanconi anaemia. Br J Haematol. 2017;178(1):32–47.
   PubMed Web of Science ®Google Scholar
• Svahn J, Bagnasco F, Cappelli E, et al. Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem-cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Association of Pediatric Hematology-Oncology). Am J Hematol. 2016;91:666–671.
   PubMed Web of Science ®Google Scholar
• Rosenberg PS, Socié G, Alter BP, et al. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105(1):67–73.
   PubMed Web of Science ®Google Scholar
• Peffault de Latour R, Porcher R, Dalle JH, et al. Allogeneic hematopoietic stem-cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122(26):4279–4286.
   PubMed Web of Science ®Google Scholar
• Ebens CL, MacMillan ML, Wagner JE. Hematopoietic cell transplantation in Fanconi Anemia: current evidence, challenges and recommendations. Expert Rev Hematol. 2017;10(1):81–97.
   PubMed Web of Science ®Google Scholar
• Bonfim CM, de Medeiros CR, Bitencourt MA, et al. HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. Biology of blood and marrow transplantation. J Am Soc Blood Marrow Transplant. 2007;13(12):1455–1460.
   PubMed Web of Science ®Google Scholar
• Pasquini R, Carreras J, Pasquini MC, et al. HLA-matched sibling hematopoietic stem cell transplantation for Fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transplant. 2008;14(10):1141–1147.
   PubMed Web of Science ®Google Scholar
• Benajiba L, Salvado C, Dalle JH, et al. HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine. Blood. 2015;125(2):417–418.
   PubMed Web of Science ®Google Scholar
• Bonfim C, Ribeiro LL, Nichele S, et al. Outcome for HLA identical related vs. unrelated donor transplants in Fanconi anemia: a single center experience using non-irradiation regimens. Presented at the 28th Annual FARF Symposium; 2016 Sep 15–18,Bellevue, WA, p. 37.
   Google Scholar
• Mehta PA, Davies SM, Leemhuis T, et al. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study. Blood. 2017;129(16):2308–2315.
   PubMed Web of Science ®Google Scholar
• Ebens CL, DeFor TE, Tryon R, et al. Comparable outcomes after HLA-matched sibling and alternative donor hematopoietic cell transplantation for children with Fanconi anemia and severe aplastic anemia. Biol Blood Marrow Transplant. 2018;24(4):765–771.
   PubMed Web of Science ®Google Scholar
• Bernard F, Uppungunduri CRS, Meyer S, et al. Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience. Br J Haematol. 2021;193(4):804–813.
   PubMed Web of Science ®Google Scholar
• Wagner JE, Eapen M, MacMillan ML, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood. 2007;109(5):2256–2262.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Zecca M, Pession A, et al. Italian pediatric group. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica. 2007;92(10):1381–1388.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Ionescu I, et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant. 2007;13(9):1073–1082.
   PubMed Web of Science ®Google Scholar
• Ruggeri A, de Latour RP, Rocha V, et al. Double cord blood transplantation in patients with high risk bone marrow failure syndromes. Br J Haematol. 2008;143(3):404–408.
   PubMed Web of Science ®Google Scholar
• Ayas M, Al-Seraihi A, El-Solh H, et al. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. Biol Blood Marrow Transplant. 2012;18(4):627–632.
   PubMed Web of Science ®Google Scholar
• MacMillan ML, DeFor TE, Young JA, et al. Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood. 2015;125(24):3798–3804.
   PubMed Web of Science ®Google Scholar
• Bonfim C, Ribeiro L, Nichele S, et al. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide for children and adolescents with Fanconi anemia. Biol Blood Marrow Transplant. 2017;23(2):310–317.
   PubMed Web of Science ®Google Scholar
• Ayas M, Siddiqui K, Al-Jefri A, et al. Successful outcome in patients with Fanconi anemia undergoing T cell-replete mismatched related donor hematopoietic cell transplantation using reduced-dose cyclophosphamide post-transplantation. Biol Blood Marrow Transplant. 2019;25(11):2217–2221.
   PubMed Web of Science ®Google Scholar
• Uppuluri R, Swaminathan VV, Ramanan KM, et al. Haploidentical stem cell transplantation with post-transplant cyclophosphamide in Fanconi anemia: improving outcomes with improved supportive care in India. Biol Blood Marrow Transplant. 2020;26(12):2292–2298.
   PubMed Web of Science ®Google Scholar
• Zubicaray J, Pagliara D, Sevilla J, et al. Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: results from the Severe Aplastic Anemia Working Party of the EBMT. Am J Hematol. 2021;96(5):571–579.
   PubMed Web of Science ®Google Scholar
• Zecca M, Strocchio L, Pagliara D, et al. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia. Biol Blood Marrow Transplant. 2014;20(4):571–576.
   PubMed Web of Science ®Google Scholar
• Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood. 2011;118(23):6006–6017.
   PubMed Web of Science ®Google Scholar
• Bertaina A, Merli P, Rutella S, et al. HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. Blood. 2014;124(5):822–826.
   PubMed Web of Science ®Google Scholar
• Mitchell R, Cole T, Shaw PJ, et al. TCR α+ β+ /CD19+ cell-depleted hematopoietic stem cell transplantation for pediatric patients. Pediatr Transplant. 2019;23(6):e13517.
   PubMed Web of Science ®Google Scholar
• Strocchio L, Pagliara D, Algeri M, et al. HLA-haploidentical TCRαβ+/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia. Blood Adv. 2021;5(5):1333–1339.
   PubMed Web of Science ®Google Scholar
• Ayas M, Saber W, Davies SM, et al. Allogeneic hematopoietic cell transplantation for Fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. J Clin Oncol. 2013;31(13):1669–1676.
   PubMed Web of Science ®Google Scholar
• Mitchell R, Wagner JE, Hirsch B, et al. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia. Br J Haematol. 2014;164(3):384–395.
   PubMed Web of Science ®Google Scholar
• Peffault de Latour R, Soulier J. How I treat MDS and AML in Fanconi anemia. Blood. 2016;127(24):2971–2979.
   PubMed Web of Science ®Google Scholar
• Giardino S, Peffault de Latour R, Aljurf M, et al. Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: a retrospective analysis on behalf of EBMT group. Am J Hematol. 2020;95(7):809–816.
   PubMed Web of Science ®Google Scholar
• Debureaux PE, Sicre De Fontbrune F, Bonfim C, et al. FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study. Bone Marrow Transplant. 2021;56(1):285–288.
   PubMed Web of Science ®Google Scholar
• Alter BP, Giri N, Pan Y, et al. Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes. Vaccine. 2014;32(10):1169–1173.
   PubMed Web of Science ®Google Scholar
• Petryk A, Kanakatti Shankar R, Giri N, et al. Endocrine disorders in Fanconi anemia: recommendations for screening and treatment. J Clin Endocrinol Metab. 2015;100(3):803–811.
   PubMed Web of Science ®Google Scholar
• Anur P, Friedman DN, Sklar C, et al. Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors. Bone Marrow Transplant. 2016;51(7):938–944.
   PubMed Web of Science ®Google Scholar
• Niewisch MR, Savage SA. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2019;12(12):1037–1052.
   PubMed Web of Science ®Google Scholar
• Townsley DM, Dumitriu B, Young NS. Bone marrow failure and the telomeropathies. Blood. 2014;124(18):2775–2783.
   PubMed Web of Science ®Google Scholar
• Calado RT, Young NS. Telomere maintenance and human bone marrow failure. Blood. 2008;111(9):4446–4455.
   PubMed Web of Science ®Google Scholar
• Ayas M, Ahmed SO. Dyskeratosis congenita. In: Aljurf MD, Gluckman E, Dufour C, editors. Congenital and acquired bone marrow failure. New York (NY): Elsevier; 2017. p. 225–233.
   Google Scholar
• Alter BP, Giri N, Savage SA, et al. Cancer in dyskeratosis congenita. Blood. 2009;113(26):6549–6557.
   PubMed Web of Science ®Google Scholar
• Ayas M. Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita: a minireview. Hematol Oncol Stem Cell Ther. 2017;10(4):285–289.
   PubMedGoogle Scholar
• Ayas M, Nassar A, Hamidieh AA, et al. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. Bone Marrow Transplant. 2013;48(9):1168–1172.
   PubMed Web of Science ®Google Scholar
• Gadalla SM, Sales-Bonfim C, Carreras J, et al. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant. 2013;19(8):1238–1243.
   PubMed Web of Science ®Google Scholar
• Ju Z, Jiang H, Jaworski M, et al. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat Med. 2007;13(6):742–747.
   PubMed Web of Science ®Google Scholar
• Barbaro P, Vedi A. Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature. Biol Blood Marrow Transplant. 2016;22(7):1152–1158.
   PubMed Web of Science ®Google Scholar
• Fioredda F, Iacobelli S, Korthof ET, et al. Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita. Br J Haematol. 2018;183(1):110–118.
   PubMed Web of Science ®Google Scholar
• Algeri M, Comoli P, Strocchio L, et al. Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimen. J Pediatr Hematol Oncol. 2015;37(4):322–326.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya R, Tan AM, Chan MY, et al. TCR αβ and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal-Hreidarsson syndrome with RTEL1 mutation. Bone Marrow Transplant. 2016;51(5):753–754.
   PubMed Web of Science ®Google Scholar
• Mahansaria SS, Kumar S, Bharathy KG, et al. Liver transplantation after bone marrow transplantation for end stage liver disease with severe hepatopulmonary syndrome in dyskeratosis congenita: a literature first. J Clin Exp Hepatol. 2015;5(4):344–347.
   PubMed Web of Science ®Google Scholar
• Giri N, Lee R, Faro A, et al. Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: case report and systematic literature review. BMC Blood Disord. 2011;11(1):3.
   PubMedGoogle Scholar
• Bartels M, Bierings M. How I manage children with Diamond-Blackfan anaemia. Br J Haematol. 2019;184(2):123–133.
   PubMed Web of Science ®Google Scholar
• Dianzani I, Loreni F. Diamond-Blackfan anemia: a ribosomal puzzle. Haematologica. 2008;93(11):1601–1604.
   PubMed Web of Science ®Google Scholar
• Ulirsch JC, Verboon JM, Kazerounian S, et al. The genetic landscape of Diamond-Blackfan anemia. Am J Hum Genet. 2018 6;103(6):930–947.
   PubMed Web of Science ®Google Scholar
• Vlachos A, Federman N, Reyes-Haley C, et al. Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Bone Marrow Transplant. 2001;27(4):381–386.
   PubMed Web of Science ®Google Scholar
• Fagioli F, Quarello P, Zecca M, et al. Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry. Br J Haematol. 2014;165(5):673–681.
   PubMed Web of Science ®Google Scholar
• Strahm B, Loewecke F, Niemeyer CM, et al. Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia. Blood Adv. 2020;4(8):1760–1769.
   PubMed Web of Science ®Google Scholar
• Faraci M, Diesch T, Labopin M, et al. Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2019;25(9):1786–1791.
   PubMed Web of Science ®Google Scholar
• Miano M, Eikema DJ, de la Fuente J, et al. Stem cell transplantation for Diamond-Blackfan anemia. A retrospective study on behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Transplant Cell Ther. 2021;27(3):274.e1–274.e5.
   PubMedGoogle Scholar
• Koyamaishi S, Kamio T, Kobayashi A, et al. Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia. Bone Marrow Transplant. 2021;56(5):1013–1020.
   PubMed Web of Science ®Google Scholar
• Bizzetto R, Bonfim C, Rocha V, et al. Eurocord and SAA-WP from EBMT. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica. 2011;96(1):134–141.
   PubMed Web of Science ®Google Scholar
• Vlachos A, Rosenberg PS, Atsidaftos E, et al. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood. 2012;119(16):3815–3819.
   PubMed Web of Science ®Google Scholar
• Vlachos A, Rosenberg PS, Atsidaftos E, et al. Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia. Blood. 2018;132(20):2205–2208.
   PubMed Web of Science ®Google Scholar
• Donadieu J, Beaupain B, Fenneteau O, et al. Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history. Br J Haematol. 2017;179(4):557–574.
   PubMed Web of Science ®Google Scholar
• Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol. 2012;19(1):44–51.
   PubMed Web of Science ®Google Scholar
• Donadieu J, Leblanc T, Bader Meunier B, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica. 2005;90(1):45–53.
   PubMed Web of Science ®Google Scholar
• Rosenberg PS, Zeidler C, Bolyard AA, et al. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol. 2010;150(2):196–199.
   PubMed Web of Science ®Google Scholar
• Choi SW, Levine J. Indications for hematopoietic cell transplantation for children with severe congenital neutropenia. Pediatr Transplant. 2010;14(8):937–939.
   PubMed Web of Science ®Google Scholar
• Fioredda F, Calvillo M, Lanciotti M, et al. Pegfilgrastim in children with severe congenital neutropenia. Pediatr Blood Cancer. 2010;54(3):465–467.
   PubMed Web of Science ®Google Scholar
• Fioredda F, Iacobelli S, van Biezen A, et al. Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation. Blood. 2015;126(16):1885–1892.
   PubMed Web of Science ®Google Scholar
• Donadieu J, Leblanc T, Bader Meunier B, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica. 2005;90:45–53.
   PubMed Web of Science ®Google Scholar
• Goobie S, Popovic M, Morrison J, et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet. 2001;68(4):1048–1054.
   PubMed Web of Science ®Google Scholar
• Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman–Diamond syndrome. Nat Genet. 2003;33(1):97–101.
   PubMed Web of Science ®Google Scholar
• Donadieu J, Michel G, Merlin E, et al. Hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transpl. 2005;36(9):787–792.
   PubMed Web of Science ®Google Scholar
• Myers KC, Furutani E, Weller E, et al. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study. Lancet Haematol. 2020;7(3):e238–e246.
   PubMed Web of Science ®Google Scholar
• Myers K, Hebert K, Antin J, et al. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome. Biol Blood Marrow Transplant. 2020;26(8):1446–1451.
   PubMed Web of Science ®Google Scholar
• Okcu F, Roberts WM, Chan KW. Bone marrow transplantation in Shwachman–Diamond syndrome: report of two cases and review of the literature. Bone Marrow Transplant. 1998;21(8):849–851.
   PubMed Web of Science ®Google Scholar
• Hsu JW, Vogelsang G, Jones RJ, et al. Bone marrow transplantation in Shwachman-Diamond syndrome. Bone Marrow Transpl. 2002;30(4):255–258.
   PubMed Web of Science ®Google Scholar
• Cesaro S, Pillon M, Sauer M, et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT). Bone Marrow Transplant. 2020;55(9):1796–1809.
   PubMed Web of Science ®Google Scholar
• Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost. 2011;37(6):673–681.
   PubMed Web of Science ®Google Scholar
• Dalle JH, Fahd M. Allogeneic stem cell transplantation in amegacaryocytosis: results of a retrospective study in EBMT centers. Biol Blood Marrow Transplant. 2014;20(2):S81–S82.
   Web of Science ®Google Scholar
• Woods G, Bajwa RP, Rose MJ. Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: report of a case and review of the literature. Pediatr Transplant. 2014;18(1):E31–E34.
   PubMed Web of Science ®Google Scholar